iSERA LIFESCIENCES LIMITED

ISERA · NSE

Information Technology · —

EOD price available after 4:30 PM IST
on the next trading day

Valuation

Blended fair value using DCF and peer comparison methods.

Insufficient data to compute intrinsic value for ISERA.

The intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.

Peer comparison

How this company stacks up against sector peers on valuation and quality metrics.

IT services & consulting · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
iSERA LIFESCIENCES LIMITED ISERA · you	₹121 Cr	-2055.7×	369.0×	—	-18.8%	—	—
Sector median	—	22.3×	3.5×	13.7×	13.8%	6.7%	19.3%
Matrimony.Com Limited MATRIMONY	₹1,169 Cr	24.5×	3.9×	17.5×	16.6%	7.4%	0.3%
Orient Technologies Limited ORIENTTECH	₹1,121 Cr	254.8×	3.5×	52.8×	1.4%	0.5%	17.6%
IZMO Limited IZMO	₹1,120 Cr	23.6×	2.7×	20.3×	11.6%	16.7%	22.8%
Dynacons Systems & Solutions Limited DSSL	₹1,081 Cr	12.8×	3.4×	7.1×	26.9%	5.9%	21.0%
Control Print Limited CONTROLPR	₹975 Cr	21.0×	2.0×	9.9×	9.6%	9.0%	16.6%
Unicommerce Esolutions Limited UNIECOM	₹972 Cr	33.0×	12.5×	—	37.9%	0.2%	—
STRING METAVERSE LIMITED META	₹963 Cr	394.5×	8.8×	—	2.7%	0.0%	—
Expleo Solutions Limited EXPLEOSOL	₹937 Cr	10.3×	1.6×	3.6×	16.0%	11.2%	21.0%

Peer comparison verdict

iSERA trades at a discount to sector peers on P/E (-2055.7× vs median 22.3×). This may signal undervaluation — or reflect lower expected growth or higher perceived risk versus the peer group.

Business quality

Valuation

P/E ratio

—

P/B ratio

—

EV/EBITDA

—

Price/Sales

—

Returns

ROE

-18.8%

ROCE

—

ROA

—

Growth

Revenue CAGR (3yr)

—

EPS CAGR (3yr)

—

Efficiency

Asset turnover

—

FCF yield

—

Dividend yield

—

Liquidity & Solvency

Debt / Equity

—

Debt / EBITDA

—

Interest coverage

—

Current ratio

—

Quick ratio

—

Financial health

Piotroski F-Score, Altman Z-Score, and key solvency ratios.

Financial health data is not yet available for this company.

Full financial data

Charts and annual statements for income, balance sheet and cash flow.

Income trend

Revenue, profit and margin trends over time.

Income statement data is unavailable for this company.

Cash flow

Where cash comes from and where it goes.

Cash flow data is not yet available for this company.

Balance sheet

Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.

Balance sheet data is not yet available for this company.

Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.

Shareholding pattern

Who owns this company and how that has changed.

Shareholding data is not yet available for this company.